Diana Auyeung-Kim

Diana Auyeung-KimDiana Auyeung-Kim, PhD, MBA, DABT

Director, Toxicology, Safety Assessment, Allergan plc

Dr. Diana Auyeung-Kim is currently a Director of Toxicology for Allergan, a Pharmaceutical Company.  She is responsible for leading nonclinical drug development projects, as well as previously managing an Operations Team. Prior to Allergan, she held various positions leading up to Associate Director at Charles River Laboratories, a Contract Research Organization, where she managed scientific and technical staff; coordinated business development and operations efforts; and conducted the scientific portions of studies.  Prior to graduate school, she was an Assistant Project Manager/Risk Assessor at Tetra Tech EM Inc., an Environmental Consulting Firm.  Dr. Auyeung-Kim has a PhD in Pharmacology and Toxicology from Virginia Commonwealth University; MBA from University of Nevada, Reno; BA in Chemistry/minor Environmental Toxicology from UC Davis; is a Diplomate of the American Board of Toxicology; and is currently a State-appointed expert to the Developmental and Reproductive Toxicant Identification Committee (Proposition 65).  She has extensive experience in networking, redefining career paths, maintaining a healthy work‑life balance, and resilience.  She is widowed and is always on the go with her son (10) and daughter (7).  In her spare time, she enjoys hosting parties, outdoor adventures in the SoCal sun, and theater performances.